home / stock / azrx / azrx news

AZRX News and Press, AzurRx BioPharma Inc. From 03/16/21

Stock Information
Company Name: AzurRx BioPharma Inc.
Stock Symbol: AZRX
Market: NASDAQ
Website: azurrx.com
Menu
AZRX AZRX Quote AZRX Short AZRX News AZRX Articles AZRX Message Board
Get AZRX Alerts

News, Short Squeeze, Breakout and More Instantly...
AZRX - AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

Top-line data expected by end of Q1 2021 DELRAY BEACH, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targe...
AZRX - Best Penny Stocks To Buy Now? 5 For Your Watch List

5 Names For Your Penny Stocks List We’re kick-starting another week where penny stocks are at the center of attention. While economic data could fuel broader markets, sentiment and momentum seem to be carrying things forward for small-cap stocks. Premarket trading in benchmark ET...

AZRX - AMC, DNN, NGA and ALT among premarket gainers

Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...

AZRX - AzurRx BioPharma launches $10M registered direct offering priced at-the-market

AzurRx BioPharma ([[AZRX]] +5.8%) entered into a securities purchase agreement with a single healthcare-focused institutional investor providing for the sale and issuance of 7,858,548 shares of common stock and warrants to purchase up to an aggregate of 3,929,274 shares at...
AZRX - AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DELRAY BEACH, Fla., March 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI...

AZRX - AzurRx BioPharma to Participate in the 33rd Annual Roth Conference

DELRAY BEACH, Fla., March 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, t...

AZRX - AzurRx BioPharma to Participate in "Fireside Chat" at the H.C. Wainwright Global Life Sciences Conference

DELRAY BEACH, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, t...
AZRX - Pandion Therapeutics, Dynatronics leads healthcare gainers; U.S. Physical Therapy, CollPlant Biotechnologies among major losers

Gainers: Pandion Therapeutics (PAND) +132%, Dynatronics (DYNT) +68%, ChromaDex (CDXC) +30%, ASLAN Pharmaceuticals (ASLN) +28%, Brookdale Senior Living (BKD) +22%.Losers: U.S. Physical Therapy (USPH) -21%, CollPlant Biotechnologies (CLGN)&...

AZRX - AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors

DELRAY BEACH, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointest...

AZRX - AzurRx BioPharma to Present at The Microcap Rodeo Winter Wonderland Conference

DELRAY BEACH, Fla., Feb. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, to...
Previous 10 Next 10